Roberts Pharmaceutical Corp.'s Ventax (doxofylline)
Executive Summary
Roberts Pharmaceutical Corp.'s Ventax (doxofylline): Bronchodilator is entering human clinical trials in the U.S. Doxofylline is also being studied in Italy by Istituto Biologico Chemioterapico, which is conducting comparative trials with Key's sustained release theophylline product, Theo-Dur. Roberts is located in Eatontown, NJ.